TAp63 plays compensatory roles in p53-deficient cancer cells under genotoxic stress

p53, p63, and p73 belong to the p53 family of proteins, which mediate development, differentiation, and various other cellular responses. p53 is involved in many anti-cancer mechanisms, such as cell cycle regulation, apoptosis, and the maintenance of genomic integrity. The p63 gene is controlled by two promoters that direct the expression of two isoforms, one with and one without transactivating properties, known as TAp63 and ΔNp63. In this study, p53-deficient cells (Hep3B and PC-3) and p53-expressing cells (A549 and HepG2) were treated with doxorubicin to examine the possible roles of TAp63 in these cells under genotoxic stress; TAp63 expression was induced in p53-deficient cell lines, but not in p53-expressing cell lines. The ectopic expression of p53 in p53-deficient cells (Hep3B) reduced TAp63 promoter activity, and knockdown of TAp63 attenuated doxorubicin-induced cell growth arrest by promoting cell cycle progression, leading to an increase in the percentage of G2/M cells. Moreover, knockdown of TAp63 increased cell sensitivity to doxorubicin-induced genomic damage. Our results suggest that TAp63 may play a compensatory role in cell cycle regulation and DNA damage repair in p53-deficient cancer cells.

Research highlights
► TAp63 expression was induced in p53-deficient cell lines, but not in p53-expressing cell lines.
► Ectopic expression of p53 in p53-deficient cell (Hep3B) reduced TAp63 promoter activity and knockdown of TAp63 attenuated doxorubicin-induced cell growth arrest by promoting cell cycle progression via increasing the percentage of G2/M cells.
► Knockdown of TAp63 increased cell sensitivity to doxorubicin-induced genomic damage.
► Our results suggest that TAp63 may play a compensatory role in p53-deficient cancer cells in cell cycle regulation and DNA damage repair.